Clinical Trial Update: Evaluation of Photosafety of BI 730357 Compared to Placebo and the Known Photosensitizing Agent Ciprofloxacin [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the photosafety of BI 730357 versus placebo and ciprofloxacin in healthy participants has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Healthy Individuals

Drugs mentioned

• BI 730357
• Ciprofloxacin (Ciprofloxacin hydrochloride)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Healthy | Phase 1 | Status: COMPLETED | Results posted: 2023-07-17